Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pediatric Rheumatology

Building Your Care Team and Long-Term Monitoring

At a Glance

Long-term PAPA syndrome care works best with a coordinated rheumatology and dermatology team that monitors inflammation and medication safety, protects joints and skin, and plans procedures carefully because minor injuries can trigger major flares.

Living with PAPA syndrome is a long-term commitment that requires a specialized team and a proactive approach to daily life. Because the condition is lifelong and symptoms can shift over time, the goal of management is not just to treat flares as they happen, but to prevent permanent damage and maintain your quality of life [1][2].

Building Your Multi-Specialty Team

No single doctor can manage all the different ways PAPA syndrome affects the body. Most patients benefit from a team that includes the following specialists:

  • Pediatric Rheumatologist: Usually the “lead” of the team, this specialist manages the systemic inflammation and joint symptoms using biologic therapies [3][4].
  • Dermatologist: Essential for managing severe acne and pyoderma gangrenosum (skin ulcers). They provide specialized wound care and skin-specific treatments [2][5].
  • Geneticist or Genetic Counselor: Helps confirm the PSTPIP1 mutation and provides guidance for other family members who may be affected or carry the gene [6][7].
  • Immunologist: May be involved to help interpret complex blood tests and understand how your specific immune system is reacting to treatments [5].
  • Physical or Occupational Therapist: Helps maintain joint mobility and strength, especially if you have had significant or frequent arthritis flares [7].
  • Mental Health Professional: Dealing with chronic pain, visible scarring, and a rare disease is emotionally taxing. Counselors can provide essential practical support for sleep, pain, body image, and school or work accommodations.

Long-Term Monitoring

Even when you are feeling well, your team will use “markers” in your blood to check for hidden inflammation, as well as perform medication-specific monitoring.

  • CRP and ESR: These are the most common tests used to track systemic inflammation. In many patients, these levels will “normalize” (return to the healthy range) when a treatment is working effectively [8][4]. However, normal CRP or ESR would not guarantee that every skin ulcer is perfectly controlled or that an infection is entirely absent.
  • Medication Safety Labs: If you take biologics, corticosteroids, or isotretinoin, you will need periodic screening for tuberculosis and hepatitis, as well as routine checks of your liver, kidneys, and lipids.
  • CBC (Complete Blood Count): Regular checks are important to monitor for anemia or low white blood cell counts, which are particularly common in the related PAMI syndrome [9][10].
  • Advanced Markers: Your doctor may occasionally check levels of IL-18 or calprotectin (MRP8/14). While these can be helpful in making a diagnosis, they don’t always change as quickly as your symptoms do, so they are often used as “big picture” indicators rather than day-to-day trackers [1][11].

Protecting Against Permanent Damage

The primary reason for aggressive treatment is to avoid irreversible complications that can sometimes occur after years of inflammation.

Joint Health

If arthritis is not well-controlled, it can lead to structural changes in the joint that a doctor can see on an X-ray or MRI. These include joint-space narrowing (where the protective cartilage wears down) and bone demineralization (weakening of the bone near the joint) [7]. These findings are not a generic consequence that every patient should expect, but in severe cases, this can lead to permanent stiffness or limited mobility [7][2].

Skin Health

Pyoderma gangrenosum and severe acne can leave behind permanent cicatrices (scars) or areas of hyperpigmentation (darker skin spots) [2]. Because these ulcers can be large and slow to heal, preventing them from starting is much easier than treating them once they have formed.

Daily Management and Pathergy Prevention

The hallmark of living with PAPA syndrome is managing pathergy—the tendency for minor injuries to turn into major inflammatory events [12][13].

  • Trauma Prevention: Practical steps like wearing knee pads or elbow guards during sports, or choosing low-impact activities, can reduce the risk of a “bump” triggering a flare [2][7].
  • Skin Protection: Use gentle, non-irritating cleansers. If you get a minor cut or scrape, clean it gently and use a moist, non-adhesive dressing [14][13]. Avoid “aggressive” treatments like scrubbing or using harsh chemicals on a wound, as this can make the inflammation worse [15]. Rapidly enlarging, painful ulcers or new pus require medical review.
  • Medical Procedures: Always inform surgeons, nurses, or dentists about your PAPA diagnosis before any procedure. Something as simple as a routine blood draw or an IV line can trigger a pathergy response [16]. Your rheumatologist, dermatologist, surgeon, and anesthesiologist must create an individualized plan together balancing pathergy, infection, wound healing, and disease control [17][18]. You must not adjust or increase your medication yourself.

Living with PAPA syndrome requires you to be an expert on your own body. By monitoring your blood work, protecting your joints and skin, and working with a dedicated team, you can manage the variable nature of this disease and focus on living a full, active life.

Common questions in this guide

Which specialists typically care for someone with PAPA syndrome?
A pediatric rheumatologist often coordinates care for inflammation and arthritis. A dermatologist, geneticist or genetic counselor, immunologist, physical or occupational therapist, and mental health professional may also help, depending on symptoms and treatment.
What tests are used to monitor PAPA syndrome over time?
CRP and ESR can track systemic inflammation. A complete blood count and medication-specific testing may monitor treatment safety, including effects on the liver, kidneys, and cholesterol levels; screening for tuberculosis and hepatitis may be needed with some medicines. IL-18 or calprotectin may be checked occasionally as broader indicators.
What does a normal CRP or ESR mean in PAPA syndrome?
A normal result can suggest that systemic inflammation is responding to treatment, but it does not prove every skin ulcer is controlled or rule out an infection. Your clinician should interpret these results together with your symptoms, skin findings, and other tests.
How can I reduce pathergy flares from everyday injuries?
Protect your joints and skin with low-impact activities or protective gear, and clean minor cuts gently with a moist, non-adhesive dressing. Avoid scrubbing and harsh chemicals; rapidly enlarging painful ulcers or new pus need prompt medical review.
What long-term damage can PAPA syndrome cause?
Poorly controlled arthritis can cause narrowing of the joint space and weakening of nearby bone, leading to stiffness or reduced mobility. Pyoderma gangrenosum ulcers and severe acne can leave permanent scars or darker skin patches, so preventing flares is important.
What should I tell my healthcare team before a procedure?
Tell surgeons, nurses, dentists, and other clinicians that you have PAPA syndrome before blood draws, IV placement, dental work, or surgery because minor trauma can trigger pathergy. Your rheumatologist, dermatologist, surgeon, and anesthesiologist should agree on an individualized plan for disease control, infection risk, and wound healing; do not change medication on your own.
How often should PAPA syndrome monitoring tests be done when I feel well?
There is no single schedule for everyone; frequency depends on your flare history, symptoms, and medicines. Even when you feel well, your team may periodically check inflammation markers and medication safety labs, so ask what monitoring schedule fits your treatment.

Get notified when new evidence is published on PAPA syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1.

    Stone DL, Ombrello A, Arostegui JI, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(2)):353-357 doi:10.1002/art.41976.

    PMID: 34492165
  2. 2

    PAPA Syndrome: Challenges in Achieving Long-Term Remission.

    Smajlović H, Prohić A

    Acta dermatovenerologica Croatica : ADC 2023; (31(2)):106-109.

    PMID: 38006373
  3. 3

    [Targeted therapy of pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome (PAPA): a case report and literature review].

    Liang WL, Li HG, Zhong G, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(12)):977-981 doi:10.3760/cma.j.cn112140-20200430-00456.

    PMID: 33256319
  4. 4

    Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome.

    Omenetti A, Carta S, Caorsi R, et al.

    Rheumatology (Oxford, England) 2016; (55(7)):1325-35 doi:10.1093/rheumatology/kew031.

    PMID: 26989109
  5. 5

    Rare Case of Pyoderma Gangrenosum in the Setting of PAPA Syndrome in a 12-Year-Old Child.

    Alhumam A

    The international journal of lower extremity wounds 2023; (22(3)):620-624 doi:10.1177/15347346211036023.

    PMID: 34382449
  6. 6

    Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome in a Chinese family: A case report and review of literature.

    Lu LY, Tang XY, Luo GJ, et al.

    World journal of clinical cases 2021; (9(22)):6393-6402 doi:10.12998/wjcc.v9.i22.6393.

    PMID: 34435004
  7. 7

    A protracted diagnostic journey of pediatric PAPA syndrome and subsequent response to tofacitinib therapy: a case report and literature review.

    He S, Deng H, Yang J, Jiang W

    Frontiers in immunology 2026; (17()):1870454 doi:10.3389/fimmu.2026.1870454.

    PMID: 42682796
  8. 8

    A de novo heterozygous PSTPIP1 variant associated with PAPA syndrome: a Chinese case report and literature review.

    Wang M, Zhang P, Shen M

    Frontiers in genetics 2026; (17()):1825761 doi:10.3389/fgene.2026.1825761.

    PMID: 42358432
  9. 9

    PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review.

    Mejbri M, Renella R, Candotti F, et al.

    Genes 2023; (14(8)) doi:10.3390/genes14081655.

    PMID: 37628706
  10. 10

    Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome.

    Zhang D, Su G, Liu Y, Lai J

    Pediatric rheumatology online journal 2021; (19(1)):151 doi:10.1186/s12969-021-00636-9.

    PMID: 34620178
  11. 11

    Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.

    Holzinger D, Fassl SK, de Jager W, et al.

    The Journal of allergy and clinical immunology 2015; (136(5)):1337-45.

    PMID: 26025129
  12. 12

    Pyoderma Gangrenosum:Recognition and Management.

    Pompeo MQ

    Wounds : a compendium of clinical research and practice 2016; (28(1)):7-13.

    PMID: 26779805
  13. 13

    Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.

    Nazir A, Zafar A

    Cureus 2022; (14(5)):e25177 doi:10.7759/cureus.25177.

    PMID: 35746991
  14. 14

    A Wound Care Specialist's Approach to Pyoderma Gangrenosum.

    Croitoru D, Naderi-Azad S, Sachdeva M, et al.

    Advances in wound care 2020; (9(12)):686-694 doi:10.1089/wound.2020.1168.

    PMID: 32320358
  15. 15

    Wound Debridement in Pyoderma Gangrenosum.

    Taheri A, Mansoori P, Sharif M

    Advances in skin & wound care 2024; (37(2)):107-111 doi:10.1097/ASW.0000000000000092.

    PMID: 38241454
  16. 16

    A surgeon's nightmare: pyoderma gangrenosum with pathergy effect mimicking necrotising fasciitis.

    Slocum AMY

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-222145.

    PMID: 29269363
  17. 17

    Postsurgical Pyoderma Gangrenosum Requiring Plastic Surgical Intervention: A Practical Review.

    Guliyeva G, Janis JE

    Plastic and reconstructive surgery. Global open 2024; (12(1)):e5505 doi:10.1097/GOX.0000000000005505.

    PMID: 38250211
  18. 18

    Perforator propeller flap for coverage of Achilles region defects caused by pyoderma gangrenosum.

    Fong CW, Bento M, Fang FJ, et al.

    JPRAS open 2022; (33()):139-144 doi:10.1016/j.jpra.2022.06.008.

    PMID: 35935517

This page explains care-team planning and long-term monitoring for PAPA syndrome for informational purposes only and does not constitute medical advice. Your rheumatologist and other specialists should guide medication changes, testing, wound care, and procedure planning.